Ameritas Investment Partners, Inc. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 119 filers reported holding CARA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.8%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,562
-40.6%
3,3110.0%0.00%
Q2 2023$9,370
-42.4%
3,3110.0%0.00%
-100.0%
Q1 2023$16,257
-58.5%
3,3110.0%0.00%
-50.0%
Q4 2022$39,136
+30.5%
3,3110.0%0.00%
+100.0%
Q3 2022$30,0000.0%3,3110.0%0.00%0.0%
Q2 2022$30,000
-25.0%
3,3110.0%0.00%0.0%
Q1 2022$40,0000.0%3,3110.0%0.00%0.0%
Q4 2021$40,000
-21.6%
3,3110.0%0.00%
-50.0%
Q3 2021$51,000
+8.5%
3,3110.0%0.00%0.0%
Q2 2021$47,000
-34.7%
3,3110.0%0.00%
-33.3%
Q1 2021$72,000
+44.0%
3,3110.0%0.00%
+50.0%
Q4 2020$50,000
+19.0%
3,3110.0%0.00%0.0%
Q3 2020$42,000
-26.3%
3,3110.0%0.00%
-33.3%
Q2 2020$57,000
+29.5%
3,3110.0%0.00%
+50.0%
Q1 2020$44,000
-17.0%
3,3110.0%0.00%0.0%
Q4 2019$53,000
-13.1%
3,3110.0%0.00%
-33.3%
Q3 2019$61,000
+3.4%
3,311
+19.7%
0.00%0.0%
Q2 2019$59,000
+9.3%
2,7650.0%0.00%0.0%
Q1 2019$54,000
+50.0%
2,7650.0%0.00%
+50.0%
Q4 2018$36,000
-45.5%
2,7650.0%0.00%
-33.3%
Q3 2018$66,000
+46.7%
2,765
+17.9%
0.00%
+50.0%
Q2 2018$45,000
+55.2%
2,3450.0%0.00%
+100.0%
Q1 2018$29,0000.0%2,3450.0%0.00%0.0%
Q4 2017$29,000
-12.1%
2,3450.0%0.00%
-50.0%
Q3 2017$33,000
-8.3%
2,3450.0%0.00%0.0%
Q2 2017$36,000
+9.1%
2,345
+32.3%
0.00%0.0%
Q1 2017$33,0001,7730.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Chescapmanager LLC 1,304,603$18,617,0002.04%
RHO CAPITAL PARTNERS INC 1,499,058$21,392,0001.96%
DAFNA Capital Management LLC 315,000$4,495,0000.94%
KINGDON CAPITAL MANAGEMENT, L.L.C. 432,178$6,167,0000.72%
Altium Capital Management LP 150,000$2,141,0000.50%
Cypress Capital Management LLC (WY) 16,743$239,0000.18%
DISCIPLINED GROWTH INVESTORS INC /MN 674,846$9,630,0000.18%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 73,902$1,055,0000.16%
FARALLON CAPITAL MANAGEMENT LLC 2,000,000$28,540,0000.12%
FIRST QUADRANT LLC/CA 71,223$1,016,0000.12%
View complete list of CARA THERAPEUTICS INC shareholders